The novel PI3K-δ inhibitor TGR-1202 enhances Brentuximab Vedotin-induced Hodgkin lymphoma cell death via mitotic arrest

Silvia Laura Locatelli, Giuseppa Careddu, G. Inghirami, L. Castagna, P. Sportelli, A. Santoro, C. Carlo-Stella

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Publication statusAccepted/In press - Sep 2 2016

ASJC Scopus subject areas

  • Medicine(all)
  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this